Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands.
Clin Exp Rheumatol. 2012 Nov-Dec;30(6):951-3. Epub 2012 Dec 17.
Patients suffering from dental infections and concurrently using immunosuppressive medication are at increased risk of developing systemic streptococcal infections. Tocilizumab is a novel therapeutic agent targeting interleukin-6. We describe a case of streptococcal lung abscesses from a dental focus after use of tocilizumab for treatment of Takayasu arteritis.
患有口腔感染且同时使用免疫抑制药物的患者发生系统性链球菌感染的风险增加。托珠单抗是一种针对白细胞介素-6 的新型治疗药物。我们描述了一例使用托珠单抗治疗 Takayasu 动脉炎后由口腔病灶引起的链球菌性肺脓肿病例。
